← Back to NON RARE IN EUROPE: Cortisol-producing adrenal tumor

NON RARE IN EUROPE: Cortisol-producing adrenal tumor

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Apr 2026Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

Mayo Clinic — PHASE2

TrialNOT YET RECRUITING
Mar 2026IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

University of Texas Southwestern Medical Center — NA

TrialRECRUITING
Feb 2026Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Johns Hopkins University — PHASE4

TrialRECRUITING
Jan 2026Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Mayo Clinic — PHASE2

TrialRECRUITING
Dec 2023Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Mayo Clinic — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for NON RARE IN EUROPE: Cortisol-producing adrenal tumor.
Check the disease page for updates →

Clinical Trial Landscape

4 active trials
1Phase 4
2Phase 2
1N/A
4Total recruiting
Search clinical trials for NON RARE IN EUROPE: Cortisol-producing adrenal tumor

Recent News & Research

No recent news articles indexed yet for NON RARE IN EUROPE: Cortisol-producing adrenal tumor.
Search PubMed for NON RARE IN EUROPE: Cortisol-producing adrenal tumor

Browse all NON RARE IN EUROPE: Cortisol-producing adrenal tumor news →

Specialist Network

No specialists currently listed for NON RARE IN EUROPE: Cortisol-producing adrenal tumor.

View all NON RARE IN EUROPE: Cortisol-producing adrenal tumor specialists →

Quick Actions